Key facts
- Fragrance companies are investigating if weight-loss drugs are influencing consumer scent preferences.
- GLP-1 drug users may seek sensory pleasure from fragrances as an alternative to food.
- The gourmand fragrance segment's share of product innovation has risen to 24% from 9% in two years.
- GLP-1 users spend 26% more on fragrances than typical consumers.
- Newer gourmand scents are evolving to include savory, spicy, and boozy notes, not just sweetness.
Perfumers are investigating whether the growing popularity of weight-loss drugs like Wegovy and Mounjaro is influencing consumer preferences for food-inspired scents. Companies such as Givaudan, IFF, CPL Aromas, and L'Oreal are exploring how these GLP-1 drugs, which can alter taste and smell, might lead users to seek pleasure from fragrances as an alternative to food.
Research suggests these drugs can have chemosensory effects, potentially increasing interest in scent as a source of sensory pleasure. Some users may find certain smells repellent while others become more appealing, with an overall trend towards increased interest in fragrance. The gourmand fragrance segment, characterized by food-like aromas, has seen significant growth, with its share of product innovation rising to 24% from 9% in two years.
Market researchers indicate that GLP-1 users spend more on beauty products, including fragrances. Perfumers are responding by developing more sophisticated scents that move beyond simple sweetness, incorporating notes like spices, spirits, and savory elements such as sesame and truffle. This evolution suggests a shift towards experiencing taste and texture through smell.